www.pharmpro.com | December 5, 2017 Applied DNA Sciences has begun initial Research and Development pilots for the manufacture of DNA for use in DNA-based therapeutics for two companies. Several other companies have requested proposals for additional DNA-based therapeutics.
Imminent Mandate by the Republic of Turkey to DNA-Tag Fertilizer Expected to Drive Demand for DNA-Tagged Fertilizers
Company to Introduce DNA-Tagged Fertilizers to Additional Markets. Demand Driven by Supply Chain Needs for Product Purity and Security, First Country to Mandate DNA Tagging of All Domestic Fertilizers. STONY BROOK, N.Y. (December 5, 2017) - Applied DNA Sciences, Inc. (NASDAQ: APDN; "Applied DNA", "the Company"), today announced that it will introduce DNA-tagged fertilizer to Turkey and countries [...]
Applied DNA to Present at the Imperial Capital 2017 Security Investor Conference on December 7 AT 9:00 AM ET
STONY BROOK, N.Y. (December 5, 2017) - Applied DNA Sciences, Inc. (NASDAQ: APDN; "Applied DNA", "the Company"), announced today that Dr. James Hayward, president & CEO, will present at Imperial Capital’s 2017 Security Investor Conference at the Intercontinental New York Barclay on Thursday, December 7 at 9:00 a.m. ET. Dr. Hayward will present to an audience of investors [...]